Does APREPITANT Cause Maternal exposure timing unspecified? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Maternal exposure timing unspecified have been filed in association with APREPITANT (CINVANTI). This represents 2.2% of all adverse event reports for APREPITANT.
124
Reports of Maternal exposure timing unspecified with APREPITANT
2.2%
of all APREPITANT reports
114
Deaths
123
Hospitalizations
How Dangerous Is Maternal exposure timing unspecified From APREPITANT?
Of the 124 reports, 114 (91.9%) resulted in death, 123 (99.2%) required hospitalization, and 119 (96.0%) were considered life-threatening.
Is Maternal exposure timing unspecified Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Maternal exposure timing unspecified?
RITUXIMAB (402)
METHOTREXATE (350)
ADALIMUMAB (343)
DICLOFENAC (331)
TOCILIZUMAB (327)
HYDROXYCHLOROQUINE (309)
FOLIC ACID (304)
INFLIXIMAB (303)
LEFLUNOMIDE (302)
SECUKINUMAB (301)
Which APREPITANT Alternatives Have Lower Maternal exposure timing unspecified Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL